Credit: REUTERS/Henry NichollsBERLIN, July 16 (Reuters) - Thermo Fisher Scientific TMO.N said on Thursday it had decided to raise its bid for Qiagen QIA.DE to 43 euros ($49.06) per share to reflect the German genetic test maker's improved business prospects since the coronavirus pandemic.
Thermo Fisher's cash offer represents a 35% premium to Qiagen's closing price on March 2, the two companies said in a statement.
($1 = 0.8764 euros)
(Reporting by Caroline Copley Editing by Michelle Martin)
((Caroline.Copley@thomsonreuters.com; +49 30 2888 5214; Reuters Messaging: caroline.copley.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
